AxoGen, Inc.

TEXARKANA, TX · Medtech · Public

Processed allograft nerve tissue and nerve repair products for peripheral nerve reconstruction

Claim this profile

Follows are private to you and power your alerts

Updated · axogeninc.com

Sector
Medtech
Headquarters
TEXARKANA, TX
Latest Form D
$1M, Oct 2011
Total capital
$1.1M
Federal grants
$103K
1 award · 2007
Rank in peer group#4 of 50
Private capital raised
$1M
1 Form D · last Oct 2011
181 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
16
24 pending · first 2025
Rank in peer group#1 of 50

Capital timeline

20072008200920102011FEDERAL ↑EQUITY ↓Cumulative $1.1M$103K1st Form D$1M
20072008200920102011FEDERAL ↑EQUITY ↓Cumulative $1.1M$103K1st Form D$1M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$1M
  • Federal grantHealth and Human S · Phase I · Long distance nerve regeneration via processed allografts in a caprine model$103K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

54months

from AxoGen, Inc.’s first federal award to its first private round.

First federal award · Apr 2007
Health and Human S · $103K
First Form D · Oct 2011
$1M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 50 peers

Line = median

Medtech · Material

  • Federal grants#4 · top 8%
  • Granted patents#1 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Brad HedgerExecutive OfficerNamed in SEC Form D filings
  • David P. HansenExecutive OfficerNamed in SEC Form D filings
  • Ernest Carabillo, Jr.DirectorNamed in SEC Form D filings
  • Gerard PlaterinkDirectorNamed in SEC Form D filings
  • Gregory G. FreitagExecutive Officer, DirectorNamed in SEC Form D filings
  • Jamie van Hamel GroomsDirectorNamed in SEC Form D filings
Show all 16 people
  • Joe MandatoDirectorNamed in SEC Form D filings
  • John P. EngelsExecutive OfficerNamed in SEC Form D filings
  • John HarperDirectorNamed in SEC Form D filings
  • John McCallumDirectorNamed in SEC Form D filings
  • Karen van Hamel ZaderejExecutive Officer, DirectorNamed in SEC Form D filings
  • Lisa Skeete TatumDirectorNamed in SEC Form D filings
  • Mark P. FriedmanExecutive OfficerNamed in SEC Form D filings
  • Mark GoldDirectorNamed in SEC Form D filings
  • Norm van Hamel WeldonDirectorNamed in SEC Form D filings
  • Robert J. RudeliusDirectorNamed in SEC Form D filings

What it has protected

USPTO · 16 granted of 40
  • PendingDrug Delivery System And Methods Of Using The SameUSPTOApplication 19672069
  • PendingDrug Delivery System And Methods Of Using The SameUSPTOApplication 19573888
  • PendingTissue Repair Membrane And Methods For Preparing The SameUSPTOApplication 19024344
Show all 40 patent records
  • Retropsoas Technologies, LLCSimilar federal contract value in Medtech · null in contracts
  • CARDIALEN, INC.Similar federal contract value in Medtech · null in contracts
  • SEEUS95 INCSimilar federal contract value in Medtech · null in contracts
  • CYTOINFORMATICS, LLCSimilar federal contract value in Medtech · null in contracts
  • PrimeraDx, Inc.Similar federal contract value in Medtech · null in contracts
  • PHOENIX NMR LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .